These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18030990)

  • 1. Profiling heparin-chemokine interactions using synthetic tools.
    de Paz JL; Moseman EA; Noti C; Polito L; von Andrian UH; Seeberger PH
    ACS Chem Biol; 2007 Nov; 2(11):735-44. PubMed ID: 18030990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
    Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
    J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
    Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
    Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines have diverse abilities to form solid phase gradients.
    Patel DD; Koopmann W; Imai T; Whichard LP; Yoshie O; Krangel MS
    Clin Immunol; 2001 Apr; 99(1):43-52. PubMed ID: 11286540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
    Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
    Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.
    Ellyard JI; Simson L; Bezos A; Johnston K; Freeman C; Parish CR
    J Biol Chem; 2007 May; 282(20):15238-47. PubMed ID: 17384413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
    Ziarek JJ; Veldkamp CT; Zhang F; Murray NJ; Kartz GA; Liang X; Su J; Baker JE; Linhardt RJ; Volkman BF
    J Biol Chem; 2013 Jan; 288(1):737-46. PubMed ID: 23148226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin.
    Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
    J Biol Chem; 2018 Nov; 293(46):17817-17828. PubMed ID: 30257866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans.
    Webb LM; Smith VP; Alcami A
    FASEB J; 2004 Mar; 18(3):571-3. PubMed ID: 14734646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry.
    Yu Y; Sweeney MD; Saad OM; Crown SE; Hsu AR; Handel TM; Leary JA
    J Biol Chem; 2005 Sep; 280(37):32200-8. PubMed ID: 16033763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of A41, a vaccinia virus chemokine binding protein.
    Bahar MW; Kenyon JC; Putz MM; Abrescia NG; Pease JE; Wise EL; Stuart DI; Smith GL; Grimes JM
    PLoS Pathog; 2008 Jan; 4(1):e5. PubMed ID: 18208323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
    Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
    J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
    Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
    Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of chemokines to glycosaminoglycan subpopulations.
    Witt DP; Lander AD
    Curr Biol; 1994 May; 4(5):394-400. PubMed ID: 7922353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.